FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas Bikfalvi

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Je-Hung Kuo; Jai-Shin Liu; Hervé Prats; Cathy Quemener; Andreas Bikfalvi; Ya-Ping Chen; Alexandre Dubrac; Wen-guey Wu; Shih-Che Sue
Alternative C-Terminal Helix Orientation Alters Chemokine Function: STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1.
Natalia Platonova; Birgit Regenfuss; Said Taouji; Eric Chevet; Claus Cursiefen; Geraldine Miquel; Andreas Bikfalvi
Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.
Patricia Fergelot; Jean-Marie Ferrière; Martin Hagedorn; John M J Herbert; Witold W Kilarski; Céline Léon; Jean-Jacques Patard; Alain Ravaud; Nathalie Rioux-Leclercq; Fabienne Soulet; Philipp Antczak; Jean-Christophe Bernhard; Nathalie Courtois; Colette Deminière; Francesco Falciani; Andreas Bikfalvi
The experimental renal cell carcinoma model in the chick embryo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas Bikfalvi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Je-Hung Kuo; Jai-Shin Liu; Hervé Prats; Cathy Quemener; Andreas Bikfalvi; Ya-Ping Chen; Alexandre Dubrac; Wen-guey Wu; Shih-Che Sue
Alternative C-Terminal Helix Orientation Alters Chemokine Function: STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1.
The Journal of biological chemistry 2013;288(19):13522-33.
2013: Natalia Platonova; Birgit Regenfuss; Said Taouji; Eric Chevet; Claus Cursiefen; Geraldine Miquel; Andreas Bikfalvi
Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.
Blood 2013;121(7):1229-37.
2013: Patricia Fergelot; Jean-Marie Ferrière; Martin Hagedorn; John M J Herbert; Witold W Kilarski; Céline Léon; Jean-Jacques Patard; Alain Ravaud; Nathalie Rioux-Leclercq; Fabienne Soulet; Philipp Antczak; Jean-Christophe Bernhard; Nathalie Courtois; Colette Deminière; Francesco Falciani; Andreas Bikfalvi
The experimental renal cell carcinoma model in the chick embryo.
Angiogenesis 2013;16(1):181-94.
2012: Fréderic Larrieu-Lahargue; Dean Y Li; Alana L Welm; Kari Alitalo; Andreas Bikfalvi; Marion Bouchecareilh; Patrick Auguste
Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.
PloS one 2012;7(6):e39540.
2011: Andreas Bikfalvi; Sophie Javerzat; Michel Moenner; Sophie North; Martin Hagedorn
Inhibition of angiogenesis and the angiogenesis/invasion shift.
Biochemical Society transactions 2011;39(6):1560-4.
2011: Isabelle Ligi; Maxime Marcelli; Alain Pascal; Cathy Quemener; Florence Sabatier; Gabrielle Sarlon; Umberto Simeoni; Stéphanie Simoncini; Edwige Tellier; Paula Frizera Vassallo; Andreas Bikfalvi; Françoise Dignat-George; Blandine Dizier; Benjamin A Guillet; Edouard Lamy; Francine Anfosso
A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants.
Blood 2011;118(6):1699-709.
2011: Rita Gupta; Anna Stincone; Philipp Antczak; Sarah Durant; Roy Bicknell; Andreas Bikfalvi; Francesco Falciani
A computational framework for gene regulatory network inference that combines multiple methods and datasets.
BMC systems biology 2011;5():52.
2011: Victor Trevino; Mahlet G Tadesse; Marina Vannucci; Fatima Al-Shahrour; Philipp Antczak; Sarah Durant; Andreas Bikfalvi; Joaquin Dopazo; Moray J Campbell; Francesco Falciani
Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.
PloS one 2011;6(3):e16492.
2010: Gregor Auf; Arnaud Jabouille; Sylvaine Guérit; Raphaël Pineau; Maylis Delugin; Marion Bouchecareilh; Noel MAGNIN; Alexandre Favereaux; Marlène Maitre; Timo Gaiser; Andreas von Deimling; Marcus Czabanka; Peter Vajkoczy; Eric Chevet; Andreas Bikfalvi; Michel Moenner
Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(35):15553-8.
2010: Rachel Cavill; Jasmin K Sidhu; Witold Kilarski; Sophie JAVERZAT; Martin Hagedorn; Timothy M D Ebbels; Andreas Bikfalvi; Hector C Keun
A combined metabonomic and transcriptomic approach to investigate metabolism during development in the chick chorioallantoic membrane.
Journal of proteome research 2010;9(6):3126-34.
2010: Virginie Lamour; Marie Le Mercier; Florence Lefranc; Martin Hagedorn; Sophie JAVERZAT; Andreas Bikfalvi; Robert Kiss; Vincent Castronovo; Akeila Bellahcène
Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model.
International journal of cancer. Journal international du cancer 2010;126(8):1797-805.
2010: Laurent Dumartin; Cathy Quemener; Hanane Laklai; John Herbert; Roy Bicknell; Corinne Bousquet; Stéphane Pyronnet; Vincent Castronovo; Martin K Schilling; Andreas Bikfalvi; Martin Hagedorn
Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells.
Gastroenterology 2010;138(4):1595-606, 1606.e1-8.
2010: Chiara Verpelli; Giulio Bertani; Valentina Cea; Monica Patti; Andreas Bikfalvi; Lorenzo Bello; Carlo Sala
Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma.
PloS one 2010;5(10):e13710.
2010: Fabienne Soulet; Witold W Kilarski; Philipp Antczak; John Herbert; Roy Bicknell; Francesco Falciani; Andreas Bikfalvi
Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model.
BMC genomics 2010;11():495.
2009: Hanane Laklai; Séverine Laval; Laurent Dumartin; Philippe Rochaix; Martin Hagedorn; Andreas Bikfalvi; Sophie Le Guellec; Marie-Bernadette Delisle; Andrew V Schally; Christiane Susini; Stéphane Pyronnet; Corinne Bousquet
Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(42):17769-74.
2009: Ahlame Saidi; Martin Hagedorn; Nathalie Allain; Chiara Verpelli; Carlo Sala; Lorenzo Bello; Andreas Bikfalvi; Sophie JAVERZAT
Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
International journal of cancer. Journal international du cancer 2009;125(5):1054-64.
2009: Laura Ragona; Simona Tomaselli; Cathy Quemener; Lucia Zetta; Andreas Bikfalvi
New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2.
Biochemical and biophysical research communications 2009;382(1):26-9.
2009: Sophie JAVERZAT; Mélanie Franco; John Herbert; Natalia Platonova; Anne-Lise Peille; Véronique Pantesco; John De Vos; Said Assou; Roy Bicknell; Andreas Bikfalvi; Martin Hagedorn
Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system.
PloS one 2009;4(11):e7856.
2009: Andreas Bikfalvi
[Tumoral angiogenesis: models, targets and inhibition].
Journal de la Société de biologie 2009;203(2):167-70.
2008: Sylvie Lemiere; Rania Azar; Francis Belloc; Demir Gürsel; Stéphane Pyronnet; Andreas Bikfalvi; Patrick Auguste
Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.
Experimental cell research 2008;314(20):3701-11.
2008: Karine Bouvrée; Bruno Larrivée; Xiang Lv; Li Yuan; Benjamin DeLafarge; Catarina Freitas; Thomas Mathivet; Christiane Bréant; Marc Tessier-Lavigne; Andreas Bikfalvi; Anne Eichmann; Luc Pardanaud
Netrin-1 inhibits sprouting angiogenesis in developing avian embryos.
Developmental biology 2008;318(1):172-83.
2008: Ahlame Saidi; Sophie JAVERZAT; Akeila Bellahcène; John De Vos; Lorenzo Bello; Vincent Castronovo; Manuel Deprez; Hugues Loiseau; Andreas Bikfalvi; Martin Hagedorn
Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
International journal of cancer. Journal international du cancer 2008;122(10):2187-98.
2008: Sallouha Aidoudi; Kinga Bujakowska; NELLY KIEFFER; Andreas Bikfalvi
The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.
PloS one 2008;3(7):e2657.
2007: Cyril Petibois; Benjamin Drogat; Andreas Bikfalvi; Gérard Déléris; Michel Moenner
Histological mapping of biochemical changes in solid tumors by FT-IR spectral imaging.
FEBS letters 2007;581(28):5469-74.
2007: Andreas Bikfalvi
Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12 Suppl 1():S59-66.
2007: Benjamin Drogat; Marion Bouchecareilh; Sophie North; Cyril Petibois; Gérard Déléris; Eric Chevet; Andreas Bikfalvi; Michel Moenner
Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells.
Journal of cellular physiology 2007;212(2):463-72.
2007: Benjamin Drogat; Patrick Auguste; Duc Thang Nguyên; Marion Bouchecareilh; Raphael Pineau; Josephine Nalbantoglu; Randal J Kaufman; Eric Chevet; Andreas Bikfalvi; Michel Moenner
IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo.
Cancer research 2007;67(14):6700-7.
2007: Witold Kilarski; Andreas Bikfalvi
[Experimental approaches to study in vivo angiogenesis].
Bulletin du cancer 2007;94 Spec No():S166-9.
2007: Laura Lasagni; Renaud Grepin; Benedetta Mazzinghi; Elena Lazzeri; Claudia Meini; Costanza Sagrinati; Francesco Liotta; Francesca Frosali; Elisa Ronconi; Nathalie Alain-Courtois; Lara Ballerini; Giuseppe Stefano Netti; Enrico Maggi; Francesco Annunziato; Mario Serio; Sergio Romagnani; Andreas Bikfalvi; Paola Romagnani
PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion.
Blood 2007;109(10):4127-34.
2007: Patrick Auguste; Lucia Fallavollita; Ni Wang; Julia Burnier; Andreas Bikfalvi; Pnina Brodt
The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation.
The American journal of pathology 2007;170(5):1781-92.
2007: Federica Pisati; Marzia Belicchi; Francesco Acerbi; Chiara Marchesi; Carlo Giussani; Manuela Gavina; Sophie JAVERZAT; Martin Hagedorn; Giorgio Carrabba; Valeria Lucini; Sergio M Gaini; Nereo Bresolin; Lorenzo Bello; Andreas Bikfalvi; Yvan Torrente
Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
Cancer research 2007;67(7):3054-63.
2007: W W Kilarski; Andreas Bikfalvi
Recent developments in tumor angiogenesis.
Current pharmaceutical biotechnology 2007;8(1):3-9.
2007: Andreas Bikfalvi
[Tumor angiogenesis].
Bulletin du cancer 2007;94(7 Suppl):F193-8.
2007: Martin Hagedorn; Maylis Delugin; Isabelle Abraldes; Nathalie Allain; Marc-Antoine Belaud-Rotureau; Michelle Turmo; claude prigent; Hugues Loiseau; Andreas Bikfalvi; Sophie JAVERZAT
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.
Cell division 2007;2():9.
2006: Ta-Chiang Liu; Tingguo Zhang; Hiroshi Fukuhara; Toshihiko Kuroda; Tomoki Todo; Xavier Canron; Andreas Bikfalvi; Robert L Martuza; Andreas Kurtz; samuel rabkin
Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6791-9.
2006: Dario Caronzolo; Valeria Lucini; Marilou Pannacci; Silvia Grosso; NELLY KIEFFER; Lorenzo Bello; Andreas Bikfalvi; Francesco Scaglione
Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection.
Antimicrobial agents and chemotherapy 2006;50(10):3277-82.
2006: Jay W Shin; Michael Min; Fréderic Larrieu-Lahargue; Xavier Canron; Rainer Kunstfeld; Lynh Nguyen; Janet E Henderson; Andreas Bikfalvi; Michael Detmar; Young Kwon Hong
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
Molecular biology of the cell 2006;17(2):576-84.
2005: Mario Gonçalves; Karine Estieu-Gionnet; Thomas Berthelot; Georges Laïn; Mireille Bayle; Xavier Canron; Natacha Betz; Andreas Bikfalvi; Gérard Déléris
Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions.
Pharmaceutical research 2005;22(8):1411-21.
2005: Sophie JAVERZAT; Andreas Bikfalvi; Martin Hagedorn
[Understanding in treating gliomas: an adequate experimental model for each question].
Bulletin du cancer 2005;92(7):633-5.
2005: Patrick Auguste; Sylvie Lemiere; Fréderic Larrieu-Lahargue; Andreas Bikfalvi
Molecular mechanisms of tumor vascularization.
Critical reviews in oncology/hematology 2005;54(1):53-61.
2005: Martin Hagedorn; Sophie JAVERZAT; Delphine Gilges; Aurélie Meyre; Benjamin de Lafarge; Anne Eichmann; Andreas Bikfalvi
Accessing key steps of human tumor progression in vivo by using an avian embryo model.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(5):1643-8.
2005: Sophie North; Michel Moenner; Andreas Bikfalvi
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors.
Cancer letters 2005;218(1):1-14.
2005: Ofra Benny; Maayan Duvshani-Eshet; Theresa G Cargioli; Lorenzo Bello; Andreas Bikfalvi; Rona S Carroll; Marcelle Machluf
Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):768-76.
2004: Andreas Bikfalvi
Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system.
Biochemical pharmacology 2004;68(6):1017-21.
2004: Lorenzo Bello; Valeria Lucini; Francesco Costa; Mauro Pluderi; Carlo Giussani; Francesco Acerbi; Giorgio Carrabba; Marilou Pannacci; Dario Caronzolo; Silvia Grosso; Svitlana Shinkaruk; Federica Colleoni; Xavier Canron; Giustino Tomei; Gérard Deleris; Andreas Bikfalvi
Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4527-37.
2004: Andreas Bikfalvi
Platelet factor 4: an inhibitor of angiogenesis.
Seminars in thrombosis and hemostasis 2004;30(3):379-85.
2004: Martin Hagedorn; Maurice Balke; Annette Schmidt; Wilhelm Bloch; Haymo Kurz; Sophie JAVERZAT; Benoît Rousseau; Joerg Wilting; Andreas Bikfalvi
VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis.
Developmental dynamics : an official publication of the American Association of Anatomists 2004;230(1):23-33.
2004: Benoît Rousseau; Fréderic Larrieu-Lahargue; Sophie JAVERZAT; Frédéric Guilhem-Ducléon; Friedrich Beermann; Andreas Bikfalvi
The tyrp1-Tag/tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity.
Cancer research 2004;64(7):2490-5.
2004: Heidi Bompais; Jalila Chagraoui; Xavier Canron; Mihaela Crisan; Xu Hui Liu; Aurora Anjo; Carine Tolla-Le Port; Marylène Leboeuf; Pierre Charbord; Andreas Bikfalvi; Georges Uzan
Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells.
Blood 2004;103(7):2577-84.
2004: Andreas Bikfalvi; Guillermo Gimenez-Gallego
The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules.
Seminars in thrombosis and hemostasis 2004;30(1):137-44.
2004: Sylvain miraux; Sylvie Lemière; Raphael Pineau; Mauro Pluderi; Paul Canioni; Jean-Michel Franconi; Eric Thiaudière; Lorenzo Bello; Andreas Bikfalvi; Patrick Auguste
Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system.
Angiogenesis 2004;7(2):105-13.
2004: Lorenzo Bello; Carlo Giussani; Giorgio Carrabba; Mauro Pluderi; Francesco Costa; Andreas Bikfalvi
Angiogenesis and invasion in gliomas.
Cancer treatment and research 2004;117():263-84.
2003: Patrick Auguste; Sophie JAVERZAT; Andreas Bikfalvi
Regulation of vascular development by fibroblast growth factors.
Cell and tissue research 2003;314(1):157-66.
2003: Lior Zilberberg; Svitlana Shinkaruk; Olivier Lequin; Benoit Rousseau; Martin Hagedorn; Francesco Costa; Dario Caronzolo; Maurice Balke; Xavier Canron; Odile Convert; Georges Laïn; Karine Gionnet; Mario Goncalvès; Mireille Bayle; Lorenzo Bello; Gérard Chassaing; Gérard Deleris; Andreas Bikfalvi
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
The Journal of biological chemistry 2003;278(37):35564-73.
2003: Benoît Rousseau; Fréderic Larrieu-Lahargue; Andreas Bikfalvi; Sophie JAVERZAT
Involvement of fibroblast growth factors in choroidal angiogenesis and retinal vascularization.
Experimental eye research 2003;77(2):147-56.
2003: Mauro Pluderi; Valeria Lucini; Dario Caronzolo; Marilou Pannacci; Francesco Costa; Giorgio Carrabba; Carlo Giussani; Silvia Grosso; Federica Colleoni; Francesco Scaglione; Roberto Villani; Andreas Bikfalvi; Lorenzo Bello
Long-term inhibition of glioma growth by systemic administration of human PEX.
Journal of neurosurgical sciences 2003;47(2):69-78.
2003: Carlo Giussani; Giorgio Carrabba; Mauro Pluderi; Valeria Lucini; Marilou Pannacci; Dario Caronzolo; Francesco Costa; Matteo Minotti; Giustino Tomei; Roberto Villani; Rona S Carroll; Andreas Bikfalvi; Lorenzo Bello
Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo.
Cancer research 2003;63(10):2499-505.
2003: Andreas Bikfalvi
[Tumor angiogenesis].
Bulletin du cancer 2003;90(5):449-58.
2003: Lorenzo Bello; Valeria Lucini; Carlo Giussani; Giorgio Carrabba; Mauro Pluderi; Francesco Scaglione; Giustino Tomei; Roberto Villani; Peter Black; Andreas Bikfalvi; Rona S Carroll
IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
Neurosurgery 2003;52(1):177-85; discussion 185-6.
2002: Martin Hagedorn; Lior Zilberberg; Jörg Wilting; Xavier Canron; Giorgio Carrabba; Carlo Giussani; Mauro Pluderi; Lorenzo Bello; Andreas Bikfalvi
Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Cancer research 2002;62(23):6884-90.
2002: Andreas Bikfalvi; Roy Bicknell
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
Trends in pharmacological sciences 2002;23(12):576-82.
2002: Lorenzo Bello; Carlo Giussani; Giorgio Carrabba; Mauro Pluderi; Valeria Lucini; Marilou Pannacci; Dario Caronzolo; Giustino Tomei; Roberto Villani; Francesco Scaglione; Rona S Carroll; Andreas Bikfalvi
Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3539-48.
2002: Sophie JAVERZAT; Patrick Auguste; Andreas Bikfalvi
The role of fibroblast growth factors in vascular development.
Trends in molecular medicine 2002;8(10):483-9.
2001: Lorenzo Bello; Valeria Lucini; Giorgio Carrabba; Carlo Giussani; Marcelle Machluf; Mauro Pluderi; Demetrios Nikas; J Zhang; Giustino Tomei; Roberto Villani; Rona S Carroll; Andreas Bikfalvi; Peter Black
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
Cancer research 2001;61(24):8730-6.
2001: Lorenzo Bello; Giorgio Carrabba; Carlo Giussani; Valeria Lucini; F Cerutti; Francesco Scaglione; J Landré; Mauro Pluderi; Giustino Tomei; Roberto Villani; Rona S Carroll; Peter Black; Andreas Bikfalvi
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
Cancer research 2001;61(20):7501-6.
2001: Rosa M Lozano; Mariano Redondo-Horcajo; Maria Angeles Jimenez; Lior Zilberberg; Pedro Cuevas; Andreas Bikfalvi; Manuel Rico; Guillermo Giménez-Gallego
Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity.
The Journal of biological chemistry 2001;276(38):35723-34.
2001: Martin Hagedorn; Lior Zilberberg; Rosa M Lozano; Pedro Cuevas; Xavier Canron; Mariano Redondo-Horcajo; Guillermo Gimenez-Gallego; Andreas Bikfalvi
A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(3):550-2.
2001: Patrick Auguste; D B Gürsel; S Lemière; Diana Reimers; Pedro Cuevas; Fernando Carceller; J P Di Santo; Andreas Bikfalvi
Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
Cancer research 2001;61(4):1717-26.
2000: Benoît Rousseau; D Dubayle; Florian Sennlaub; Jean-Claude Jeanny; Pierre Costet; Andreas Bikfalvi; Sophie JAVERZAT
Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells.
Experimental eye research 2000;71(4):395-404.
2000: Martin Hagedorn; Andreas Bikfalvi
Target molecules for anti-angiogenic therapy: from basic research to clinical trials.
Critical reviews in oncology/hematology 2000;34(2):89-110.
1999: Jouan Hureaux Valerie; Xavier Canron; M Alemany; Jacques Caen; G Quentin; J Plouet; Andreas Bikfalvi
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action.
Blood 1999;94(3):984-93.
1999: Eric Chevet; G Lemaître; N Janjic; Denis Barritault; Andreas Bikfalvi; M D Katinka
Fibroblast growth factor receptors participate in the control of mitogen-activated protein kinase activity during nerve growth factor-induced neuronal differentiation of PC12 cells.
The Journal of biological chemistry 1999;274(30):20901-8.
1998: C Perollet; Z C Han; C Savona; Jacques Caen; Andreas Bikfalvi
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.
Blood 1998;91(9):3289-99.
1997: C Savona; Sophie JAVERZAT; C Perollet; Andreas Bikfalvi
[Angiogenesis and neoangiogenesis].
La Revue du praticien 1997;47(20):2239-43.
1997: Andreas Bikfalvi; Sophie JAVERZAT; C Perollet; C Savona
[Angiogenesis and cancer].
Bulletin du cancer 1997;84(9):885-90.
1995: X F Gu; Andreas Bikfalvi; Y Z Chen; Jacques Caen; ZC Han
Constitutive and selective expression of basic fibroblast growth factor in human leukaemia cell lines.
European journal of haematology 1995;55(3):189-94.
1994: Andreas Bikfalvi; ZC Han
Angiogenic factors are hematopoietic growth factors and vice versa.
Leukemia 1994;8(3):523-9.
1992: Andreas Bikfalvi; ZC Han; G Fuhrmann
Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells.
Blood 1992;80(8):1905-13.
1992: ZC Han; Andreas Bikfalvi; Z X Shen; E Bodevin
Recombinant acidic human fibroblast growth factor (aFGF) stimulates murine megakaryocyte colony formation in vitro.
International journal of hematology 1992;55(3):281-6.
1991: Andreas Bikfalvi; C Sauzeau; H Moukadiri; Jacques Maclouf; N Busso; M Bryckaert; J Plouet; Gérard Tobelem
Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Journal of cellular physiology 1991;149(1):50-9.
1990: Andreas Bikfalvi; J Alterio; A L Inyang; E Dupuy; M Laurent; M P Hartmann; L Vigny; Daniel Raulais; Yves Courtois; Gérard Tobelem
Basic fibroblast growth factor expression in human omental microvascular endothelial cells and the effect of phorbol ester.
Journal of cellular physiology 1990;144(1):151-8.
1990: A L Inyang; Andreas Bikfalvi; H Lu; Gérard Tobelem
Chloroquine's modulation of endothelial cell activity induced with basic fibroblast growth factor and human serum: effect on mitogenesis, protease production and cell migration.
Cell biology international reports 1990;14(1):35-46.
1989: E Dupuy; Andreas Bikfalvi; Francine Rendu; S L Toledano; Gérard Tobelem
Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels.
Experimental cell research 1989;185(2):363-72.
1989: Andreas Bikfalvi; Jocelyne Enouf; Raymonde Bredoux; A Lompre; E Dupuy; N Bourdeau; Sylviane Levy-Toledano; Gérard Tobelem
Evidence of endoplasmic reticulum-related Ca2+ ATPase in human microvascular endothelial cells.
Experimental cell research 1989;184(1):28-36.
1989: Andreas Bikfalvi; E Dupuy; A L Inyang; N Fayein; G Leseche; Yves Courtois; Gérard Tobelem
Binding, internalization, and degradation of basic fibroblast growth factor in human microvascular endothelial cells.
Experimental cell research 1989;181(1):75-84.
1989: G Leseche; Andreas Bikfalvi; E Dupuy; G Tobelem; B Andreassian; J Caen
Prelining of polytetrafluoroethylene grafts with cultured human endothelial cells isolated from varicose veins.
Surgery 1989;105(1):36-45.
1988: Andreas Bikfalvi; E Dupuy; C Ruan; Gérard Tobelem; G Leseche; J Caen
Binding of heparin to human microvascular endothelial cells and the effect on proliferation.
Cell biology international reports 1988;12(11):931-42.